North East and North Cumbria
ICS Formulary
ICS Formulary
10 Musculoskeletal and joint diseases
10-02-01 Anticholinesterases
Links
County Durham and Tees Valley Guidance for Prescribing and Monitoring in Post Bariatric Surgery in Primary Care
Guidelines for the Management of Adults with Asymptomatic Liver Blood Test Abnormalities- NHS England Urgent Clinical Commissioning Policy Statement (170018/P)
- NICE HST22: Ataluren for treating Duchenne muscular dystrophy with a nonsense mutation in the dystrophin gene
- NICE TA588: Nusinersen for treating spinal muscular atrophy
- NICE TA748: Mexiletine for treating the symptoms of myotonia in non-dystrophic myotonic disorders
- NICE TA755: Risdiplam for treating spinal muscular atrophy
- NICE TA940: Ravulizumab for treating generalised myasthenia gravis (terminated appraisal)
- NICE TA941: Ravulizumab for treating AQP4 antibody-positive neuromyelitis optica spectrum disorder (terminated appraisal)
- NICE TA960: Satralizumab for preventing relapses in neuromyelitis optica spectrum disorders
- North of Tyne, Gateshead and North Cumbria - Management of patients, post-bariatric surgery in primary care
- NTAG: Transanal irrigation (TAI) systems (Peristeen Plus®, Aquaflush®, and QuFora®) for neurogenic bowel dysfunction, chronic constipation and chronic faecal incontinence